Brainsway (BRSYF) Cash from Financing Activities (2019 - 2026)
Brainsway (BRSYF) reported Cash from Financing Activities of -$901000.0 for Q1 2026, down 19.34% on a YoY basis from -$1.1 million in Q1 2025, and up 8.71% quarter-over-quarter from -$987000.0 in Q4 2025.
Brainsway (BRSYF) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Brainsway has reported Cash from Financing Activities for 8 years, with the latest figure at -$901000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 19.34% year-over-year to -$901000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (down 113.04% YoY), and the FY2025 full-year result was -$1.7 million, down 109.36% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$901000.0, up from -$987000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $19.6 million in Q4 2024, with the low at -$987000.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged $739705.9 across 5 years, with a median of -$377000.0 in 2023.
- The largest YoY upside for Cash from Financing Activities was 3816.32% in 2024 against a maximum downside of 1146.43% in 2024.
- Brainsway's Cash from Financing Activities stood at -$73000.0 in 2022, then sank by 621.92% to -$527000.0 in 2023, then jumped by 3816.32% to $19.6 million in 2024, then tumbled by 105.04% to -$987000.0 in 2025, then rose by 8.71% to -$901000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$901000.0 (Q1 2026), -$987000.0 (Q4 2025), and -$208000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Brainsway | - | - | 11.68 Mn | -901,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -901,000.00 |
| Mar 31, 2026 | -901,000.00 |
| Dec 31, 2025 | -987,000.00 |
| Dec 31, 2025 | -987,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | -755,000.00 |
| Mar 31, 2025 | -755,000.00 |
| Dec 31, 2024 | 19.59 Mn |
| Dec 31, 2024 | 19.59 Mn |
| Sep 30, 2024 | -698,000.00 |
| Sep 30, 2024 | -698,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -589,000.00 |
| Mar 31, 2024 | -589,000.00 |
| Dec 31, 2023 | -527,000.00 |
| Dec 31, 2023 | -527,000.00 |